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Patterns in the relationship between life expectancy 
and gross domestic product in Russia in 2005–15: 
a cross-sectional analysis
Vladimir M Shkolnikov, Evgeny M Andreev, Rustam Tursun-zade, David A Leon
Summary
Background Since 2005, Russia has made substantial progress, experiencing an almost doubling of per-capita gross 
domestic product by purchasing power parity (GDP [PPP]) to US$24 800 and witnessing a 6-year increase in life 
expectancy, reaching 71·4 years by 2015. Even greater gains in GDP (PPP) were seen for Moscow, the Russian capital, 
reaching $43 000 in 2015 and with a life expectancy of 75·5 years. We aimed to investigate whether mortality levels 
now seen in Russia are consistent with what would be expected given this new level of per-capita wealth.
Methods We used per-capita GDP (PPP) and life expectancy from 61 countries in 2014–15, plus those of Russia as a 
whole and its capital Moscow, to construct a Preston curve expressing the relationship between mortality and national 
wealth and to examine the positions of Russia and other populations relative to this curve. We adjusted life expectancy 
values for Moscow for underestimation of mortality at older ages. For comparison, we constructed another Preston 
curve based on the same set of countries for the year 2005. We used the stepwise replacement algorithm to decompose 
mortality differences between Russia or Moscow and comparator countries with similar incomes into age and cause-
of-death components.
Findings Life expectancy in 2015 for both Russia and Moscow lay below the Preston-curve-based expectations by 
6·5 years and 4·9 years, respectively. In 2015, Russia had a lower per-capita income than 36 of the comparator 
countries but lower life expectancy than 60 comparator countries. However, the gaps between the observed and the 
Preston-expected life expectancy values for Russia have diminished by about 25% since 2005, when the life expectancy 
gap was 8·9 years for Russia and 6·6 years for Moscow. When compared with countries with similar level of income, 
the largest part of the life expectancy deficit was produced by working-age mortality from external causes for Russia 
and cardiovascular disease at older ages for Moscow.
Interpretation Given the economic wealth of Russia, its life expectancy could be substantially higher. Sustaining the 
progress seen over the past decade depends on the ability of the Russian Government and society to devote adequate 
resources to people’s health.
Funding This work was partly funded through the International Project on Cardiovascular Disease in Russia supported 
by a Wellcome Trust Strategic Award (100217) and was supported by the Russian Academic Excellence Project 5-100.
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 
4.0 license.
Introduction
Mortality correlates with income across countries, with 
high-income countries usually having lower mortality 
than poorer countries. In 1975, this relationship was 
investigated by Samuel Preston in an article that was 
republished in 2007 with commentaries by the author 
and other scholars.1 In this influential study, the life 
expectancy at birth of countries around the world was 
found to be related to their gross national income 
per capita, a quantity that is frequently used as a marker 
of national wealth, living standards, and economic 
development. Preston showed that the cross-sectional 
relationship between life expectancy and per-capita 
national income across countries can be accurately 
described by the so-called Preston curve, with rapid in-
creases in life expectancy in countries with lower incomes 
and slower increases in countries with higher incomes. 
Over time, the Preston curve tends to shift upwards 
(panel), reflecting improve ments in life expectancy 
independent of national income (eg, due to adoption of 
medical advances).
However, since the mid-1960s, Russian life expectancy 
and mortality patterns have differed strikingly from those 
in most industrialised countries that follow, on average, 
the Preston curve.10,11 Russia has always stood out as being 
an exception to Preston’s regular pattern. Para doxically, 
between 1965 and 1984, the decrease in life expectancy in 
Russia and the Soviet Union coincided with growth in the 
income and wealth levels of the population.12 After a short-
term improvement in life expectancy in 1985–87 that has 
been attributed to Gorbachev’s anti-alcohol campaign, the 
health of the Russian population started to decline again 
Articles
e182 www.thelancet.com/public-health   Vol 4   April 2019
and continued to do so throughout the 1990s, triggered by 
the abrupt return of easy access to alcohol and the 
economic and social stresses coinciding with the end of 
the Soviet Union.10,11 These develop ments led to dramatic 
increases in mortality in 1992–94 and 1999–2003.10,11 In the 
early 2000s, Russia had low levels of life expectancy and 
per-capita gross domestic product (GDP).11
In 2005–15, Russia’s situation improved substantially: 
per-capita GDP by purchasing power parity (GDP 
[PPP]) doubled to US$24 800 and the country’s life 
expectancy increased by 6 years to 71·4 years. The 
developments in the capital city of Moscow deserve 
particular attention. In both the communist and the 
post-communist eras, Muscovites benefited from 
higher wealth and lower mortality compared with the 
Russian population as a whole. In 2015, the city’s per-
capita GDP (PPP) was $43 000 (80% higher than Russia) 
and its life expectancy was 75·5 years (4·1 years higher 
than Russia).
In this Article, we investigate whether, after the 
improvements in 2005–15, Russia and its capital city 
remain outliers in the life expectancy–GDP (PPP) 
relationship defined by the Preston curve. We consider 
negative deviations below the curve as excess losses of 
human lifetime relative to those expected of countries with 
a given level of per-capita national wealth. Additionally, we 
seek to identify the major components of the life expectancy 
deficits in Russia and Moscow by decomposing the life 
expectancy differences by cause of death between these 
two populations on one side and countries with the same 
levels of per-capita GDP (PPP) on the other.
Methods
Populations and timepoints
We assessed the positions of Russia and Moscow at several 
timepoints according to average per-capita income and life 
expectancy relative to the broader international experience. 
We compare Moscow with Russia because, since the early 
2000s, the capital city has had a much higher life 
expectancy and average income compared with the rest of 
Russia. We consider Russia as a whole rather than Russia 
without Moscow because our main focus is on Russia 
and we wanted to facilitate quantitative international 
comparisons and excluding Moscow, which comprises 
8% of the national population, does not substantially 
change the Russian position (−0·4 years of life expectancy 
and −7% of per-capita GDP).
Although life expectancy began to increase in Russia 
after 2003,10,11 in the first 2 years the positive changes were 
small and inconsistent across age groups. We have 
therefore taken 2005 as the earliest year for Russia and 
Moscow, when these trends had stabilised.
To build the Preston curve, we used data for 61 countries 
on life expectancy in 2005 and in 2015 (or 2014 where data 
were not available) and per-capita GDP (PPP) in 2005 and 
2015 (measured in US dollars for the year in question). 
These countries comprise all those that have life tables 
computed by the direct method from vital statistics on 
age-specific deaths and population exposures.
Data sources
The life expectancy data in 2014–15 for 61 countries other 
than Russia were extracted from the Human Mortality 
Database;13 the Eurostat Database;14 the Health for All 
Database;15 the database of the Pan American Health 
Organization;16 and the databases of the national statistical 
agencies of Canada,17 Singapore,18 and South Korea.19 The 
countries’ per-capita GDP (PPP) values were derived 
from the World Bank.20 For Moscow, the comparable 
per-capita values were obtained using the regional GDP 
methodology by Zubarevich.21
Life expectancy for Russia and Moscow in 2005, 2010, 
and 2015 was calculated from the official mortality data 
by the Russian Statistical Service (Rosstat). Using our 
Research in context
Evidence before this study
The Preston curve first published in 1975 describes the 
relationship between national life expectancy at birth and 
gross domestic product (GDP) per capita among countries. 
In 2001, we showed that life expectancy in Russia in 1995–96 
was lower than was anticipated from the Preston curve. Over 
the period 2005–15, life expectancy and GDP per capita both 
increased substantially, leading to the question as to whether 
Russia’s life expectancy was still less than might be expected 
given its per-capita GDP. We have regularly monitored the 
Russian and international literature in this field and were not 
aware of any other attempt to address this question.
Added value of this study
To our knowledge, this study is the first to show that, despite 
substantial improvements in national wealth per capita since 
2005, Russia and its capital city, Moscow, remain outliers, 
underperforming in terms of life expectancy. Compared with 
other countries with similar levels of GDP per capita, the deficit 
in life expectancy is driven in part by excess mortality at working 
ages, whereas for Moscow, it is cardiovascular disease at older 
ages that is important.
Implications of all the available evidence
Russia needs to make better use of its wealth to improve the 
life expectancy of its population if its recent progress is to be 
sustained into the future. Investing more extensively and 
effectively in public health and primary prevention and 
addressing health inequalities will be crucial here.
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previous estimates,22 we calculated the life expectancy 
values for Moscow for these years, which were adjusted 
for underestimation of mortality at older ages. These 
estimates were lower than the original Rosstat life 
expectancy estimates by 0·2 years in 2005, 0·4 years in 
2010, and 1·0 years in 2015.
Data on causes of death were extracted from the 
Russian Fertility and Mortality Database23 (Russia and 
Moscow in 2015) and from the WHO Mortality Database24 
(Belgium, Croatia, Canada, Finland, Hungary, Poland, 
and the UK in 2014–15). Possible intercountry differ-
ences in coding practices are minimal at the level of 
the ten broad cause-of-death categories used in our 
decomposition analysis. Given an unexpected and 
supposedly artificial rise in deaths from senility in 
Russia after 2011,25 we take into account in our 
interpretation the possible overstatement of this ill-
defined category at the expense of under statement of 
cardiovascular disease at ages 80 years and older in 
Russia and Moscow.
Statistical analysis
To build the Preston curve, we use the simplest loga- 
rithmic form3
where index i indicates the country, εi is the random error 
specific to that country, and a and b are param eters to be 
estimated. Calculations of the parameters and standard 
statistics to assess model fit (R² and F-test) were done 
using the command curve estimation in SPSS. For our 
modelled curves, we found that 68–71% of the life 
expectancy variance could be explained by the per-capita 
GDP, with high statistical significance of the relationship 
(p<0·0001). We observed no pattern in the regression 
residuals plotted against the fitted values.
The deviations of Russia and Moscow from the 
Preston curve were calculated as differences between 
the GDP-based life expectancy values obtained from our 
logarithmic model and the observed values of life 
expectancy in those years.
Although earlier studies have examined mortality and 
life expectancy differences between Russia and national 
populations with much higher levels of income such as 
France and the UK,10,11 the present study decomposes, by 
age and causes of death, the differences in life expectancy 
between countries with the same levels of per-capita 
GDP as Russia or Moscow. For Russia, these countries 
are Romania, Croatia, Hungary, and Poland, whereas for 
Moscow, they are the UK, Finland, Canada, and Belgium. 
We identified these countries by choosing four countries 
that had the closest per-capita GDP (PPP) to Russia or 
Moscow, a similar level of Socio-Demographic Index, and 
were positioned closer to the Preston curve.
Decomposition of a difference between two life 
expectancies is a demographic method to assess the 
contri butions of different age groups and causes of 
death (within these groups) to the total life expectancy 
differ ences between two populations. In this study, 
decompositions of life expectancy gaps between 
Russia and Moscow on one side and the eight 
comparator countries on the other side were done with 
the stepwise replacement algorithm.26 This general 
method executes a chain of replacements of elementary 
age-cause-specific death rates in one population by 
corresponding rates from another population and vice 
versa and calculates life expectancy effects after each 
replacement.
We used SPSS version 25.0 to fit the regression model 
and Excel for life expectancy decompositions.
Panel: The Preston curve shift
The Preston curve is similar in shape to the logarithmic curve, with income along the 
x-axis and life expectancy along the y-axis. According to this formal relationship, the 
variation in life expectancy across countries per US$100 increase in per-capita national 
income is characterised by a steep increase in life expectancy among countries with low 
levels of income and a much slower increase in life expectancy among countries with high 
levels of national income.
A single Preston curve reflects a cross-sectional relationship in one period. Comparing 
these relationships between different time periods (1900s, 1930s, and 1960s) and taking 
into account differences in purchasing power, Preston found that the curves shifted 
upwards with time—ie, to higher life expectancies—with minor changes in shape. 
This pattern of change between periods suggested that the life expectancy increase over 
time was mostly attributable to the growing ability of the same amount of income to 
essentially buy more lifetime. Preston estimated that this accounted for 75–90% of the 
increase in life expectancy over time. This change was thought to operate through general 
improvements in knowledge about prevention and treatment diffusing across countries 
irrespective of levels of national income. The modern version of the Preston curve uses 
the per-capita GDP (PPP) as the measure of national wealth. More recent analyses have 
shown that the Preston relationship between life expectancy and per-capita GDP (PPP) 
has continued over the 1970s–2000s and still fits well with empirical data.2–4
The classic vertical shift of the Preston curve over time is visible even amid declines in 
national income. Notably, decreases in mortality rates in European countries were 
sustained between 2003 and 2012 despite the great economic recession of 2008 with 
the concomitant stagnation or decline in national wealth.5 In particular, Spain and Italy 
experienced persistently high longevity despite abrupt deteriorations in the labour 
market, which led to dramatic drops in the fraction of lifetime spent in employment.6,7 
More broadly, since the 1980s, life expectancy in many developing countries has 
increased substantially with little growth in national income. Furthermore, a recent 
Global Burden of Disease analysis8 has shown that mortality corresponding to the same 
level of their Socio-Demographic Index tends to decline with time.
Altogether, although these findings suggest that national income is an important 
resource for improvement of health, higher national wealth does not automatically 
result in improved health or increased survival.9 However, a study4 of European countries 
has found that over the past three decades, increases in life expectancy have been more 
closely associated with national wealth than in earlier periods. The authors suggest that 
this is because of the growing contribution of cutting-edge medical technologies to 
mortality decline whose adoption requires substantial increased investment in 
equipment and expertise.
GDP (PPP)=gross domestic product by purchasing power parity.
LEi = a + b · log(GDPi) + εi
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Role of the funding source
The funders of the study had no role in study design; 
data collection, analysis, or interpretation; or writing of 
the report. The authors had full access to all the data in 
the study and the corresponding author had final 
responsibility for the decision to submit for publication.
Results
Between 2005 and 2015, Russia experienced rapid growth 
in per-capita GDP (PPP) combined with a gain of 
6 additional years of life expectancy. Most of this GDP 
growth occurred between 2005 and 2010, with almost no 
improvement in the following 5 years (figure 1). The rise 
in life expectancy continued in 2011–15, albeit at a slower 
pace. A similar trajectory, but at higher levels of GDP 
(PPP) and life expectancy, was observed for Moscow. In 
terms of both GDP (PPP) and life expectancy, the levels 
for Moscow in 2005 were close to the levels for Russia in 
2015. In 2005–10, per-capita GDP (PPP) in Moscow grew 
by 65% and reached levels similar to those of several 
established market economies. Between 2010 and 2015, 
per-capita GDP (PPP) in Moscow did not rise.
Despite this progress, life expectancy for both Russia 
and Moscow in 2005 and 2015 was well below the line of 
the Preston curve (figure 1). In 2005, the difference 
between the observed and the expected life expectancy 
values was 8·9 years for Russia and 6·6 years for Moscow; 
in 2015, these differences decreased to 6·5 years for 
Russia and 4·9 years for Moscow. For Russia, these 
differences were the largest negative deviations among 
all countries considered in both years, whereas for 
Moscow they were the fourth and third largest negative 
deviations, respectively. In 2014–15, Russia’s per-capita 
GDP (PPP) was nearly the same as in Croatia, Romania, 
Uruguay, Hungary, and Poland, all of which had 
appreciably higher life expectancy (figure 1). Over the 
same period, Russia’s life expectancy was similar to that 
of Kyrgyzstan and Moldova and was slightly lower than 
that of Ukraine, El Salvador, and Belarus, where the per-
capita GDP (PPP) values were lower than those in Russia.
In 2015, Russia was positioned close to Kazakhstan in 
the life expectancy–GDP space, but Moscow had no close 
neighbour (figure 1). Although Moscow had a per-capita 
GDP (PPP) level similar to that of Finland, the UK, 
Belgium, Canada, and Italy, it lagged behind these 
countries in life expectancy by 5–7 years. The life 
expectancy of the Moscow population was similar to that 
of Latvia, Macedonia, Hungary, and Ecuador, all of which 
had a per-capita GDP (PPP) lower than Moscow.
Between 2005 and 2015, the differences between the 
observed and the expected life expectancy values 
diminished by approximately 25% (by 2·3 years for 
Russia and 1·7 years for Moscow). The vertical or almost 
vertical moves in the 2011–15 period for both Moscow 
and Russia reduced but did not eliminate the negative 
vertical deviations from the Preston curve. In these years, 
life expectancy was increasing with stagnating or even 
diminishing national income. Thus, both Moscow and 
Russia as a whole moved to be somewhat more in line 
with the other countries.
In 2015, the four countries with average incomes closest 
to Russia were in eastern Europe; all four lay below the 
Preston curve, with distances from the curve varying 
from 0·2 years in Hungary to 2·5 years in Romania. The 
life expectancy gaps between Russia and these comparator 
countries varied from 4·6 years (Hungary vs Russia) to 
6·1 years (Poland vs Russia; figure 2).
For each of the four comparator countries, the breakdown 
of the life expectancy gap with Russia was similar in terms 
of the distribution of the age and cause components 
(figure 2). The greatest contributions were produced by 
differences in mortality at working ages (ie, 15–64 years), 
mostly from the increased mortality from external causes 
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Figure 1: Life expectancy and GDP (PPP) for 61 nations for the 2014–15 period, the Preston curves for 2005 
and 2014–15, and the positions of Russia and Moscow in 2005, 2010, and 2015
The figure shows the Preston curve for 2005 (dashed) and for 2014–15 (solid). Comparator countries for Russia are 
marked in yellow and comparator countries for Moscow are marked in blue. AUS=Australia. AUT=Austria. 
BEL=Belgium. BGR=Bulgaria. BLR=Belarus. BOL=Bolivia. CAN=Canada. CHE=Switzerland. CRI=Costa Rica. 
CRO=Croatia. CZE=Czech Republic. DEU=Germany. ECU=Ecuador. ESP=Spain. EST=Estonia. FIN=Finland. 
HUN=Hungary. IRL=Ireland. ITA=Italy. JPN=Japan. KAZ=Kazakhstan. KGZ=Kyrgyzstan. LUX=Luxemburg. 
LTU=Lithuania. LVA=Latvia. MAC=Macedonia. MDA=Moldova. NLD=Netherlands. NOR=Norway. PAN=Panama. 
POL=Poland. ROU=Romania. SGP=Singapore. SLV=El Salvador. SVK=Slovakia. SVN=Slovenia. SWE=Sweden. 
UKR=Ukraine. URY=Uruguay. GDP (PPP)=gross domestic product by purchasing power parity in US dollars.
Figure 2: Age-cause-specific components of the life expectancy gaps 
between Russia or Moscow and international comparators in 2014–15
Each panel shows age-cause-specific contributions to the total differences in life 
expectancy between Russia or Moscow and the countries with the closest average 
per-capita income. The four upper panels show results of decompositions of the 
gaps between four countries and Russia in 2014–15 whereas the four bottom 
panels show similar decompositions for Moscow. Each panel shows vertical bars 
corresponding to contributions of mortality differences within 5-year age groups 
to the total life expectancy difference. Coloured parts within each vertical bar 
correspond to contributions of differences in mortality from selected causes 
within the age groups to the total life expectancy difference. GDP (PPP)=gross 
domestic product by purchasing power parity in US dollars.
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Age group (years)
Comparators vs Moscow
Comparators vs Russia
Romania
GDP (PPP): $22 071
Total gap: 5·6 years 
Cause of death
Cerebrovascular disorders Ischaemic heart disease Other circulatory diseases Infectious diseases Neoplasms
Hungary
GDP (PPP): $26 436
Total gap: 4·6 years 
Croatia
GDP (PPP): $22 489
Total gap: 6·0 years 
Poland
GDP (PPP): $26 856
Total gap: 6·1 years 
UK
GDP (PPP): $41 767
Total gap: 5·6 years 
Canada
GDP (PPP): $44 205
Difference: 6·7 years 
Finland
GDP (PPP): $42 275
Total gap: 5·9 years 
Belgium
GDP (PPP): $45 608
Difference: 5·8 years 
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in Russia. Smaller but substantial contri butions were 
produced by mortality differences at older ages, mostly 
from ischaemic heart disease and cerebrovascular 
disorders. The summary contribution of the Russian 
mortality excess at all ages younger than 60 years was 
2·2 times (Poland) to 4·5 times (Romania) greater than the 
contribution of all ages older than 60 years.
In 2015, the comparator countries for Moscow were 
established market economies of western Europe and 
North America. The four comparator countries lay above 
the Preston curve with the vertical distances varying 
from 0·1 years (Belgium) to 1·5 years (Canada; figure 1). 
The gaps from Moscow vary from 5·4 years (Belgium vs 
Moscow) to 6·7 years (Canada vs Moscow; figure 2). Here, 
a major role is played by the excess in cardiovascular 
mortality at older ages in Moscow, with smaller but 
substantial contributions of external causes at working 
ages. The components produced by the excess mortality 
of Muscovites at all ages older than 60 years were nearly 
the same as components produced by all ages younger 
than 60 years.
In all eight comparisons, the excess in mortality at 
older ages (especially at ages 85 and older) in Russia 
and Moscow from ischaemic heart disease and cerebro-
vascular disorders was partly counterbalanced by 
opposite contributions related to the group of other 
circulatory diseases and other causes of death (figure 2); 
these findings might result from peculiarities of Russia 
in diagnostics and coding of causes of death among the 
older population, as acknowledged in the Methods.
Discussion
This study examined the relationship between life 
expectancy and per-capita GDP in Russia and its much 
wealthier capital city Moscow in comparison with 
61 other countries by means of the Preston curve. Russia 
and Moscow’s large negative deviations from the curve in 
2015 can be regarded as estimates of losses of human life 
that could, in principle, have been avoided if Russia’s 
considerable national wealth were more effectively 
orientated towards improving the population’s health.
This study highlights the rapid economic growth in 
Russia that had, by 2015, allowed the country to overtake 
many eastern European nations in terms of per-capita 
GDP. Moscow has benefited especially, with a recent per-
capita GDP comparable to that of many established 
market economies. Although life expectancy did not 
always increase with national income, economic growth 
in Russia in 2005–10 was accompanied by a rise in health 
expenditure and general living standards and thus by a 
substantial increase in life expectancy.11 Our results have 
also shown that since 2010, life expectancy continued to 
increase even though per-capita GDP stagnated. This 
movement could be viewed as following the classic 
upwards shift that was first described by Preston’s curves 
from different epochs. It suggests that after four decades 
of predominant mortality increase, including the acute 
crisis of the 1990s, Russia is finally improving survival 
and that the lifestyles and circumstances of the Russian 
population are changing for the better.
However, in spite of this progress, life expectancy in 
Russia and in Moscow in 2015 still remains well below 
the estimate offered by the Preston curve, by 6·5 years 
for Russia and 4·9 years for Moscow. Russia has lower 
per-capita GDP (PPP) than 36 of our considered 
countries, whereas it has lower life expectancy than 
60 of those countries—all except for Bolivia. Meanwhile, 
Moscow has lower per-capita GDP (PPP) than only 
14 countries but has lower life expectancy than 
41 countries. Closing the 6·5-year gap for Russia will take 
time: according to the Human Mortality Database,13 
when the UK’s life expectancy was at the same level as 
Russia’s current life expectancy, it took the UK 34 years 
(from 1966 to 2000) to gain 6·5 years of lifetime. 
Strikingly, Estonia made such a gain in just 15 years 
(2001–16), illustrating that with modern approaches to 
health care and prevention, such improvements are 
possible in post-Soviet countries with high starting levels 
of mortality over relatively short periods.
Our study throws light on the specific causes of death 
that underlie the deficit in life expectancy seen in Russia 
relative to countries with similar levels of GDP per capita. 
Figure 2 suggests that each of the comparator countries 
differs markedly from either Russia or Moscow in terms 
of mortality structure by age and cause. However, the 
ways in which they deviate from Russia or Moscow are 
very similar, underlining that Russia and Moscow are 
distinctive outliers for given levels of national wealth 
not just in terms of level of mortality, but also in terms of 
age and cause structure of mortality.
The deficit in life expectancy relative to countries with 
similar levels of GDP per capita is mainly explained by 
high mortality from external causes at working ages and 
from cardiovascular disease at older ages. The first is 
particularly important in the comparisons between 
Russia and central and eastern European countries, 
whereas the second is more pronounced in comparisons 
between Moscow and western countries.
There are many factors that underlie high external 
cause and cardiovascular mortality in Russia. Behavioural 
factors include a high prevalence of hazardous alcohol 
consumption and male smoking. Smoking increases risk 
of death from a wide range of conditions from cancers to 
cardiovascular disease. Similarly, alcohol drinking has 
widespread effects on survival as a consequence of 
injuries and violence, but also through its effect on risk 
of premature deaths from heart attacks and stroke.27,28 In 
Moscow and other regions, alcohol-related and external 
cause mortality has decreased substantially. Alcohol 
policy measures implemented in 2005–07, which 
included stricter control of alcohol manufacture, 
processing, and sale, were followed by substantial drops 
in mortality.10 This result is consistent with evidence that 
after the mid-2000s, the Russian population experienced 
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decreases in consumption of vodka, although the present 
levels are still high.29 The other positive development is a 
reduction in male smoking that has been apparent since 
around 2010,30,31 although once again it is still much 
higher than in other high-income countries.
An adverse profile of drinking and smoking can only 
explain part of the life expectancy deficit, particularly 
among women who have historically had lower prevalence 
of smoking and heavy drinking. We have previously shown 
that there is substantial inter-regional variation in cardio-
vascular mortality across Russia, which is the main reason 
for little change in inter-regional variation in life expectancy 
in the 2000s and 2010s.32 Part of this regional difference in 
cardiovascular mortality is likely to reflect variations in the 
ability of regional health systems to reduce the burden of 
cardiovascular disease, which requires modernisation of 
detection and treatment in primary care as well as 
investment in modern diagnostic and interventional 
technologies. These differences might be exacerbated by 
regional differences in levels of financing of the medical 
care system including exceptionally favourable positions of 
Moscow and a few other regions. Nevertheless, since 2010, 
Russia has experienced an important rise in the availability 
of cardiovascular surgery and centres capable of carrying 
out emergency percutaneous coronary interventions.10,33 
However, in Russia overall, per-capita expenditure on 
health—in cluding public health—remains lower than in 
most neighbouring countries.34 One of the more alarming 
features of the low level of investment in and effectiveness 
of public health in Russia is the alarming ten-fold growth 
in deaths from HIV/AIDS from 2005 to 2015. For the time 
being, this serious situation has minimal impact on life 
expectancy as deaths from HIV/AIDS account for only 
1% of all deaths in 2015.
Other important factors behind the life expectancy 
deficit in Russia are related to human insecurity (ie, 
technical and organisational measures to prevent fatal 
accidents), weaknesses in policing and enforcement, and 
suboptimal safety standards. In synergy with alcohol, 
these factors elevate risks of fatal injuries and violent 
death. The current level of mortality from these causes 
suggests that the financial resources allocated to 
addressing these challenges are still insufficient or are 
being used ineffectively. It is well established that high 
levels of income inequality are related to lower life 
expectancy.35–37 In line with Russia’s pronounced 
socioeconomic inequality and related social stress, there 
are large gaps in the mortality levels and trends of the 
better-off and the worse-off population groups in Russia. 
It has been previously shown that this inequality is indeed 
slowing Russia’s progress towards better health.38,39
At the most general level, the issue of inadequate 
government investment in policies and actions to improve 
human health, safety, and welfare might tie in with the 
fact that in Russia, a high share of GDP comes from 
extractive industries. It has been shown that countries that 
depend heavily on the mining sector tend to spend a 
smaller proportion of their wealth on health and education 
than do other countries and to have life expectancies that 
lie substantially below the Preston curve.40
Finally, in Russia there is a common belief that the 
country’s poor health and high mortality are to be con-
sidered natural and inevitable because of the economic 
backwardness of the country. Thus, Russians often blame 
their poor health and high mortality on Russia’s poverty. 
Our study shows that this perception is wrong because 
Russian mortality is far higher than it should be given 
the level of national wealth per capita. Put simply, the 
economic wealth of Russia is more than sufficient to allow 
its population to have a higher level of life expectancy.
Our study had limitations. We were restricted to a set of 
61 countries chosen because of their reliable mortality 
statistics. Therefore, the data cover only a part of the 
world’s population, with a strong bias towards European, 
North American, central Asian, and Latin American 
regions that are much closer to Russia with respect to their 
epidemiological profiles than the Indian subcontinent or 
Africa. However, inclusion of these regions if the data had 
been of adequate quality would be unlikely to affect 
Russia’s position relative to the Preston curve compared 
with the comparator countries that we did analyse. In 
addition, mortality at ages 80 years or older is understated 
in both Russia and Moscow, meaning that our data risked 
underestimating the life expectancy gap. However, for the 
whole of Russia, this data shortcoming does not produce 
visible changes in life expectancy at birth; for Moscow, we 
adjusted life expectancy values for old-age mortality 
understatement. As usual, international cause-of-death 
comparisons are problematic because of possible 
inconsistency of diagnostics and coding practices across 
countries. However, we minimised this problem by using 
only ten very broad diagnostic categories. It is, nonetheless, 
still possible that at ages 80 years and older, Russian 
mortality from ill-defined and some other causes is 
overstated whereas mortality from cardio vascular diseases 
is somewhat understated.
In conclusion, thanks to the recent progress outlined 
in this Article, Russia has reduced the distance of its life 
expectancy from the value predicted by the Preston curve 
by about a quarter but remains considerably below it. 
Despite this positive trend, future developments are hard 
to predict given the long legacy of neglect and under-
financing of the Russian health system. In this context, 
it is particularly worrying that since 2012, increases in the 
Russian health expenditure have been slowing down 
and the federal state budget’s part of this expenditure 
(ie, the most reliable part) has been shrinking.41,42 The 
sustainability of current levels of progress towards the 
Preston curve depends on the willingness of Russian 
leadership and society to devote adequate attention as 
well as resources to the country’s health.
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